Expertise in
13
conditions

Lingyun X. Sun

22 Hankou Road, 
Nanjing, CN 
Expertise in
13
conditions
22 Hankou Road, 
Nanjing, CN 

Overview

Lingyun Sun practices practicing medicine in Nanjing, China.

Sun is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Glomerulonephritis, Rheumatoid Arthritis (RA), and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 661 peer reviewed articles and participating in 3 clinical trials.

Locations

22 Hankou Road, Nanjing, 210093, China
Other Locations
No. 321 Zhongshan Road, Nanjing, 210008, China
321 Zhongshan Road, Nanjing, 210008, China
NO.321 Zhongshan Road, Nanjing, China
140 Hanzhong Road, Nanjing, 210029, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Chinese Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Chinese Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drug: Ixekizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

661 Total Publications

Study of Nuclear Effects on Charm Production in Light-Ion Collisions.
Study of Nuclear Effects on Charm Production in Light-Ion Collisions.
Journal: Physical review letters
Published: May 26, 2026

Frequently Asked Questions about Lingyun X. Sun

Is Lingyun X. Sun a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Lingyun X. Sun is classified as an Distinguished expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lingyun X. Sun participate in research or clinical trials?

Yes. Lingyun X. Sun has published 661 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Lingyun X. Sun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sun's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 55 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile